WO2005124011A1 - Keratin based hydrogel sheets prepared from fabric for biomedical and other applications and method of production - Google Patents

Keratin based hydrogel sheets prepared from fabric for biomedical and other applications and method of production Download PDF

Info

Publication number
WO2005124011A1
WO2005124011A1 PCT/US2005/020404 US2005020404W WO2005124011A1 WO 2005124011 A1 WO2005124011 A1 WO 2005124011A1 US 2005020404 W US2005020404 W US 2005020404W WO 2005124011 A1 WO2005124011 A1 WO 2005124011A1
Authority
WO
WIPO (PCT)
Prior art keywords
fabric
wool
composition
hydrogel
flannel
Prior art date
Application number
PCT/US2005/020404
Other languages
French (fr)
Inventor
Keith Edward Branham
James Perry English
Donald R. Cowsar
Original Assignee
Keraplast Technologies, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keraplast Technologies, Ltd. filed Critical Keraplast Technologies, Ltd.
Publication of WO2005124011A1 publication Critical patent/WO2005124011A1/en

Links

Classifications

    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M11/00Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising
    • D06M11/32Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with oxygen, ozone, ozonides, oxides, hydroxides or percompounds; Salts derived from anions with an amphoteric element-oxygen bond
    • D06M11/50Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with oxygen, ozone, ozonides, oxides, hydroxides or percompounds; Salts derived from anions with an amphoteric element-oxygen bond with hydrogen peroxide or peroxides of metals; with persulfuric, permanganic, pernitric, percarbonic acids or their salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225Mixtures of macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/18Manufacture of films or sheets
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M11/00Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising
    • D06M11/32Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with oxygen, ozone, ozonides, oxides, hydroxides or percompounds; Salts derived from anions with an amphoteric element-oxygen bond
    • D06M11/36Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with oxygen, ozone, ozonides, oxides, hydroxides or percompounds; Salts derived from anions with an amphoteric element-oxygen bond with oxides, hydroxides or mixed oxides; with salts derived from anions with an amphoteric element-oxygen bond
    • D06M11/38Oxides or hydroxides of elements of Groups 1 or 11 of the Periodic System
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M23/00Treatment of fibres, threads, yarns, fabrics or fibrous goods made from such materials, characterised by the process
    • D06M23/10Processes in which the treating agent is dissolved or dispersed in organic solvents; Processes for the recovery of organic solvents thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2438/00Living radical polymerisation
    • C08F2438/01Atom Transfer Radical Polymerization [ATRP] or reverse ATRP
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2389/00Characterised by the use of proteins; Derivatives thereof
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M2101/00Chemical constitution of the fibres, threads, yarns, fabrics or fibrous goods made from such materials, to be treated
    • D06M2101/02Natural fibres, other than mineral fibres
    • D06M2101/10Animal fibres
    • D06M2101/12Keratin fibres or silk

Definitions

  • the current disclosure extends the known technology to incorporate numerous keratin-containing fabrics and other structures and improves the present technology by allowing some or all of these original structures to be retained and by allowing materials other than keratin (i.e. from fabric blends) to be intimately incorporated into the keratin matrix.
  • the products of the current disclosure are preferably not derived from raw animal starting products and are potentially safer for medical uses. Processes using raw material as the starting substrate require that the keratin protein materials be further processed in most cases, (for example, cast as a film) and/or incorporated into other forms (for example, a bandage). In the current disclosure the material requires much less, if any, further processing to produce a final product.
  • the current disclosure allows the original structure of the fabric material to be wholly or partially retained, thus allowing the properties of the final product to be determined by the choice of the type of fabric or other structural material used as the starting material 1 as well as the processing conditions.
  • the products and processes of the present disclosure are amenable to continuous processing like that used in the textile industry. Summary
  • the present disclosure provides in part, for the direct preparation of hydratable sheets, hydrogel sheets, and/or viscoelastic hydrogel sheets by utilizing readily available fabrics and allows the properties or texture of the final product to be determined by the choice of fabric starting material as well as by the processing conditions.
  • the present disclosure utilizes blends of keratm-containing fabric with other natural and synthetic blends to prepare composite sheet materials with natural and synthetic fiber imbedded in an oxidized or reduced keratin matrix.
  • the disclosed materials are also produced from three-dimensional weavings of keratin-based materials allowing the preparation of bulk materials, composite bulk materials, and more complex shapes.
  • the disclosed methods can be used to directly prepare finished products or can be used to prepare intermediate materials to finished products, and are amenable to continuous processing as well as batch processing.
  • the present disclosure may be described therefore in certain embodiments as a composition that includes a wool containing fabric, wherein the wool, or the fabric has been treated to produce a pre-hydrogel such that the wool in the fabric forms a hydrogel upon contact with water.
  • the wool is treated by oxidation and ion exchange.
  • the fabric may be treated to partially block a portion of the cystine side chains from oxidation prior to an oxidation step.
  • Such treatment may include any of various methods known in the art, including by not limited to disulfide bonds to thiol containing chemicals such as thioglycolate or ⁇ -mercaptoethanol, lanthionization or sulfitolysis.
  • Partial oxidation can also be achieved by controlling the oxidation conditions without pretreatment of the fabric.
  • oxidation treatment comprises soaking the fabric in an aqueous solution of from about 1-3% hydrogen peroxide at a temperature of from abo / ut 70° to about 100°C for a period of about 1-2 hours.
  • Preferred ion exchange treatment may comprise soaking the fabric in 0.1M NaOH or 0.1 M NH4OH for about 16-20 hours.
  • Preferred lanthionization conditions include soaking the fabric in a solution of a hydroxide base in a non-aqueous solvent at a temperature of 20°-30°C for about 18-24 hours, and in preferred embodiments the fabric is soaked in a non-aqueous solution of 1.5% KOH, NaOH,
  • the lanthionization treatment may comprise soaking the fabric in a solution of a hydroxide base in an alcohol or aprotic solvent, wherein the solvent may include ethanol, methanol, isopropanol, dimethylformamide, dimethyldisulfoxide, N- methylpyrrolidione, or hexamethylphosphoramide.
  • the lanthionization treatment comprises soaking the fabric in a 1.5% KOH/ETOH solution for a period of about 16-24 hours.
  • any type of keratin containing fabric can be used in practicing the present disclosure, and in certain embodiments the preferred fabric is a woven fabric comprising wool or a non-woven fabric comprising wool, and wherein the fabric may be wool felt, flannel, gabardine, worsted wool flannel, worsted wool flannel-cotton blend, worsted wool gabardine, or wool jersey knit.
  • the wool fabric may also be wool blended with cotton, polyester, rayon, silk, or nylon.
  • any of the treated wool containing fabrics disclosed or suggested herein may be used as a wound dressing.
  • the present disclosure thus includes wound dressings made from any of the disclosed treated fabrics.
  • the wound dressing may be in the form of a sheet and is preferably in essentially the same form as the fabric prior to treatment.
  • the treated fabric may be stored in sterile, hermetically sealed packages prior to use and hydrated upon opening, or allowed to hydrate by contact with a wound.
  • the wound dressing of the disclosure are thus individual wound dressing contained in single use packages or they are continuous rolls of material that are cut to the needed size and shape when used.
  • the disclosed wound dressing thus make excellent field dressings for use by the military, by outdoor sportsmen and women or in any other situation in which a first aid kit is employed.
  • the treated fabric may further include drags or medicines to deliver to the wound including but not limited to analgesics, antibacterials, antibiotics, antifungals, anti- inflammatories, antivirals, cytokines, growth factors, or combinations of these.
  • the hydrogel fabric may also deliver water soluble keratin peptides to a wound during use, either peptides that are added to the fabric during production or that naturally occur in the wool and are released upon hydration or contact with a wound. It is understood that the wound dressings may be used on human and animal subjects.
  • the hydrogel forming fabrics may be used in the treatment of chronic wounds or in the production of an artificial skin for use in burns or surgical wounds.
  • the fabric may include a plasticizer or a backing material such as a surgical mesh as needed for structural strength.
  • a wool or keratin containing fabric may be woven into a three dimensional shape prior to treatment and maintains its shape after oxidation.
  • Such three dimensional materials may be used as implants for bulking of soft tissue or as spinal disc or intra-articular implants, for example.
  • the three dimensional shapes may also include porous regions for ingrowth of skin, muscle, bone or other tissue types as a tissue engineering scaffold.
  • the present disclosure also includes films made from the keratin containing fabrics.
  • films may include plasticizers such as glycerol, and preferably from 10-40% w/w glycerol.
  • the film is produced by subjecting the fabric and plasticizer to a pressure of about 8,000-8,500 pounds at 130° to 150°C.
  • the wound dressings may include a backing material or polymeric binders.
  • Preferred binders include but are not limited to resorbable binders such as polylactic acid polymers, polyglycolic acid polymers, and polylactic acid-polyglycolic acid copolymers, or non-resorbable binders such as ethyl cellulose, cellulose acetate, and polyethylene.
  • resorbable binders such as polylactic acid polymers, polyglycolic acid polymers, and polylactic acid-polyglycolic acid copolymers, or non-resorbable binders such as ethyl cellulose, cellulose acetate, and polyethylene.
  • the present disclosure includes hydratable solid sheets derived from any fabric composed wholly or partly of keratin, both woven and non- woven, and including blends with other natural and synthetic fibers such as cotton, nylon, rayon, silk, polyester, etc.
  • the fabric is wool fabric such as wool felt, flannel, gabardine, worsted wool flannel, worsted wool flannel-cotton blend, worsted wool gabardine, wool jersey knit, and the like.
  • the wool fabric is pretreated by certain processes such as lanthionization, reduction, reduction followed by oxidation, oxidation followed by reduction, and in other embodiments the fabric is directly oxidized without pretreatment in aqueous environment using an oxidizing agent such as hydrogen peroxide, H 2 O .
  • an oxidizing agent such as hydrogen peroxide, H 2 O .
  • S-S disulfide bonds
  • cystine linkages are oxidized to form sulfonic acid groups.
  • the sulfonic acid and other acid groups in the keratin can be subsequently ion-exchanged (neutralized) using a base such as HjOH, NaOH, or KOH which results in a hydratable material, hydrogel, or viscoelastic hydrogel upon the application of water.
  • samples of worsted wool gabardine (wwg), 3.01 g were directly oxidized in 50 mL of a 1.68% w/w H 2 O 2 solution containing 1% w/v acetic acid at 75°C for 4 hours. At this time the solution containing the wwg was cooled to ambient temperature, isolated by vacuum filtration, and dried in a vacuum oven. The dried samples were treated with excess 0.1M NaOH overnight, then isolated by decantation and vacuum dried.
  • samples of wwg, 3.03 g were directly oxidized in 50 mL of a 3.00 % w/v H 2 O 2 solution containing 1% w/v acetic acid at 100°C for 2 hours. At this time the solution containing the wwg was cooled to ambient temperature isolated by vacuum filtration, and dried in a vacuum oven. The dried samples were treated with excess 0.1M NaOH overnight, then isolated by decantation and vacuum dried.
  • the fabric samples were treated with glycerol, from about 10% w/w up to about 30 % w/w, as a plasticizer and pressed in a Carver press at 130° to 150°C.
  • the resulting films exhibited a continuum of strength ranging from hard and brittle to tough and flexible. Treatment of some of these materials with water yields materials reminiscent of skin.

Abstract

Keratin hydrogels and films are produced from woven and non-woven wool fabrics. The hydrogels and films retain the structure of the fabric and are useful for wound dressings and other medical applications.

Description

Title of the Invention
Keratin Based Hydrogel Sheets Prepared from Fabric for Biomedical and Other Applications and Method of Production
Background of the Invention [0001] The chemical treatment of raw animal products containing keratin (hair, wool, fur skin, horn, hooves, or bird feet, beaks, and feathers) has been shown by the present applicant to produce keratin protein products with reduced, reactive suliϊde moieties and/or containing sulfonic acid groups that increase the hydration and solubility of the keratin proteins, resulting in useful products in various fields including, but not limited to, medical, veterinary, and dental applications, orthopedics, wound and pain care, soft tissue bulking and replacement, tissue engineering, implants and coatings, and agricultural uses. Active and useful products have been produced as powders, gels, sheets, both woven and unwoven, hydrogels and solids. The current disclosure extends the known technology to incorporate numerous keratin-containing fabrics and other structures and improves the present technology by allowing some or all of these original structures to be retained and by allowing materials other than keratin (i.e. from fabric blends) to be intimately incorporated into the keratin matrix.
[0002] The products of the current disclosure are preferably not derived from raw animal starting products and are potentially safer for medical uses. Processes using raw material as the starting substrate require that the keratin protein materials be further processed in most cases, (for example, cast as a film) and/or incorporated into other forms (for example, a bandage). In the current disclosure the material requires much less, if any, further processing to produce a final product. The current disclosure allows the original structure of the fabric material to be wholly or partially retained, thus allowing the properties of the final product to be determined by the choice of the type of fabric or other structural material used as the starting material1 as well as the processing conditions. Finally, the products and processes of the present disclosure are amenable to continuous processing like that used in the textile industry. Summary
[0003] The present disclosure provides in part, for the direct preparation of hydratable sheets, hydrogel sheets, and/or viscoelastic hydrogel sheets by utilizing readily available fabrics and allows the properties or texture of the final product to be determined by the choice of fabric starting material as well as by the processing conditions. The present disclosure utilizes blends of keratm-containing fabric with other natural and synthetic blends to prepare composite sheet materials with natural and synthetic fiber imbedded in an oxidized or reduced keratin matrix. The disclosed materials are also produced from three-dimensional weavings of keratin-based materials allowing the preparation of bulk materials, composite bulk materials, and more complex shapes. The disclosed methods can be used to directly prepare finished products or can be used to prepare intermediate materials to finished products, and are amenable to continuous processing as well as batch processing.
[0004] The present disclosure may be described therefore in certain embodiments as a composition that includes a wool containing fabric, wherein the wool, or the fabric has been treated to produce a pre-hydrogel such that the wool in the fabric forms a hydrogel upon contact with water. In preferred embodiments the wool is treated by oxidation and ion exchange. It is understood that the fabric may be treated to partially block a portion of the cystine side chains from oxidation prior to an oxidation step. Such treatment may include any of various methods known in the art, including by not limited to disulfide bonds to thiol containing chemicals such as thioglycolate or β-mercaptoethanol, lanthionization or sulfitolysis. After such pre-treatment, only a portion of the cystine side chains are available for oxidation and the control of the amount of oxidation allows the control of the hydratabihty characteristics of the hydrogel. Partial oxidation can also be achieved by controlling the oxidation conditions without pretreatment of the fabric.
[0005] Any appropriate oxidant may be used, including but not limited to hydrogen peroxides, organic peracids, peroxy carbonates, ammonium sulfate peroxide, benzoyl peroxide or perborates, and in certain preferred embodiments oxidation treatment comprises soaking the fabric in an aqueous solution of from about 1-3% hydrogen peroxide at a temperature of from abo / ut 70° to about 100°C for a period of about 1-2 hours. Preferred ion exchange treatment may comprise soaking the fabric in 0.1M NaOH or 0.1 M NH4OH for about 16-20 hours.
Preferred lanthionization conditions include soaking the fabric in a solution of a hydroxide base in a non-aqueous solvent at a temperature of 20°-30°C for about 18-24 hours, and in preferred embodiments the fabric is soaked in a non-aqueous solution of 1.5% KOH, NaOH,
NK OH, LiOH, or Ca(OH)2.
[0006] In alternative embodiments the lanthionization treatment may comprise soaking the fabric in a solution of a hydroxide base in an alcohol or aprotic solvent, wherein the solvent may include ethanol, methanol, isopropanol, dimethylformamide, dimethyldisulfoxide, N- methylpyrrolidione, or hexamethylphosphoramide. In yet further embodiments, the lanthionization treatment comprises soaking the fabric in a 1.5% KOH/ETOH solution for a period of about 16-24 hours. [0007] Any type of keratin containing fabric can be used in practicing the present disclosure, and in certain embodiments the preferred fabric is a woven fabric comprising wool or a non-woven fabric comprising wool, and wherein the fabric may be wool felt, flannel, gabardine, worsted wool flannel, worsted wool flannel-cotton blend, worsted wool gabardine, or wool jersey knit. The wool fabric may also be wool blended with cotton, polyester, rayon, silk, or nylon.
[0008] In certain embodiments of the disclosure, any of the treated wool containing fabrics disclosed or suggested herein may be used as a wound dressing. The present disclosure thus includes wound dressings made from any of the disclosed treated fabrics. The wound dressing may be in the form of a sheet and is preferably in essentially the same form as the fabric prior to treatment. The treated fabric may be stored in sterile, hermetically sealed packages prior to use and hydrated upon opening, or allowed to hydrate by contact with a wound. The wound dressing of the disclosure, are thus individual wound dressing contained in single use packages or they are continuous rolls of material that are cut to the needed size and shape when used. The disclosed wound dressing thus make excellent field dressings for use by the military, by outdoor sportsmen and women or in any other situation in which a first aid kit is employed.
[0009] The treated fabric may further include drags or medicines to deliver to the wound including but not limited to analgesics, antibacterials, antibiotics, antifungals, anti- inflammatories, antivirals, cytokines, growth factors, or combinations of these. In preferred embodiments the hydrogel fabric may also deliver water soluble keratin peptides to a wound during use, either peptides that are added to the fabric during production or that naturally occur in the wool and are released upon hydration or contact with a wound. It is understood that the wound dressings may be used on human and animal subjects. [00010] In certain embodiments the hydrogel forming fabrics may be used in the treatment of chronic wounds or in the production of an artificial skin for use in burns or surgical wounds. In certain embodiments, therefore the fabric may include a plasticizer or a backing material such as a surgical mesh as needed for structural strength. [00011] In certain preferred embodiments, a wool or keratin containing fabric may be woven into a three dimensional shape prior to treatment and maintains its shape after oxidation. Such three dimensional materials may be used as implants for bulking of soft tissue or as spinal disc or intra-articular implants, for example. The three dimensional shapes may also include porous regions for ingrowth of skin, muscle, bone or other tissue types as a tissue engineering scaffold.
[00012] As described above, the present disclosure also includes films made from the keratin containing fabrics. Such films may include plasticizers such as glycerol, and preferably from 10-40% w/w glycerol. In preferred embodiments the film is produced by subjecting the fabric and plasticizer to a pressure of about 8,000-8,500 pounds at 130° to 150°C. [00013] In certain embodiments, the wound dressings may include a backing material or polymeric binders. Preferred binders include but are not limited to resorbable binders such as polylactic acid polymers, polyglycolic acid polymers, and polylactic acid-polyglycolic acid copolymers, or non-resorbable binders such as ethyl cellulose, cellulose acetate, and polyethylene.
[00014] Throughout this disclosure, unless the context dictates otherwise, the word "comprise" or variations such as "comprises" or "comprising," is understood to mean "includes, but is not limited to" such that other elements that are not explicitly mentioned may also be included. Further, unless the context dictates otherwise, use of the term "a" may mean a singular object or element, or it may mean a plurality, or one or more of such objects or elements.
Detailed Description
[00015] The present disclosure includes hydratable solid sheets derived from any fabric composed wholly or partly of keratin, both woven and non- woven, and including blends with other natural and synthetic fibers such as cotton, nylon, rayon, silk, polyester, etc. In certain embodiments of the invention the fabric is wool fabric such as wool felt, flannel, gabardine, worsted wool flannel, worsted wool flannel-cotton blend, worsted wool gabardine, wool jersey knit, and the like. In certain embodiments the wool fabric is pretreated by certain processes such as lanthionization, reduction, reduction followed by oxidation, oxidation followed by reduction, and in other embodiments the fabric is directly oxidized without pretreatment in aqueous environment using an oxidizing agent such as hydrogen peroxide, H2O . Upon oxidation at least some portion of the disulfide bonds (S-S) in cystine linkages are oxidized to form sulfonic acid groups. The sulfonic acid and other acid groups in the keratin can be subsequently ion-exchanged (neutralized) using a base such as HjOH, NaOH, or KOH which results in a hydratable material, hydrogel, or viscoelastic hydrogel upon the application of water. In each case some or all of the original fabric structure is maintained allowing such properties as the degree of hydration, the texture and surface finish, and the strength to be manipulated based upon the properties of the starting fabric. In certain cases where a fabric blend of keratin-containing fabric with a fabric that does not contain keratin, for example, a worsted wool flannel-cotton blend, is utilized, unique properties such as unidirectional elasticity can be achieved. In still other cases where keratin-containing materials produced from three-dimensional weaving are utilized, bulk materials and more complex shapes can be prepared.
Description of Preferred Processes
[00016] In one embodiment of the process, samples of worsted wool gabardine (wwg), 3.01 g, were directly oxidized in 50 mL of a 1.68% w/w H2O2 solution containing 1% w/v acetic acid at 75°C for 4 hours. At this time the solution containing the wwg was cooled to ambient temperature, isolated by vacuum filtration, and dried in a vacuum oven. The dried samples were treated with excess 0.1M NaOH overnight, then isolated by decantation and vacuum dried.
[00017] In another embodiment of the process, samples of wwg, 3.03 g, were directly oxidized in 50 mL of a 3.00 % w/v H2O2 solution containing 1% w/v acetic acid at 100°C for 2 hours. At this time the solution containing the wwg was cooled to ambient temperature isolated by vacuum filtration, and dried in a vacuum oven. The dried samples were treated with excess 0.1M NaOH overnight, then isolated by decantation and vacuum dried. [00018] In yet another embodiment of the process, 5 squares of worsted wool flannel (wwf), 11.92 g, were mixed with 198 mL of 2% H2O2 and heated to reflux (100°C) over a period of approximately 30 minutes. Reflux was continued for 1.5 hours at which time the reaction mixture was cooled to 25°C, isolated by gravity filtration, washed with deionized water, and dried under vacuum. Next, one square was treated with 200 mL of 0.1 M NELtOH for approximately 18 hours, isolated by decantation, washed with 2 x 200 mL of deionized water, and vacuum dried. The dried samples retained the original fabric structure. This sample exhibited hydrogel properties when treated with water.
[00019] In another embodiment of the process where the fabric is pretreated before oxidation: 15 squares of worsted wool flannel, 30.60 g, were mixed with 750 mL of 1.5% w/v KOH in ethanol and allowed to stand for approximately 18 hours. Next the fabric squares were isolated by vacuum filtration and washed with 2 x 800 ml. of deionized water, and dried under vacuum. Next the dried pretreated squares, 34.97 g, were mixed with 581 mL of 2% H2O2 and heated to reflux (100°C) over a period of approximately 30 minutes. Reflux was continued for 1.5 hours at which time the reaction mixture was cooled to 25°C, isolated by gravity filtration, washed with deionized water, and dried under vacuum. Next, one square was treated with 200 mL of 0.1 M NE rOH for approximately 18 hours, isolated by decantation, washed with 2 x 200 mL of deionized water, and vacuum dried. The dried samples retained the original fabric structure. This sample exhibited hydrogel properties when treated with water. [00020] In each of the four embodiments of the process described above films were prepared from the fabric samples directly after oxidation (before treatment with NaOH or NFLtOH). The fabric samples were treated with glycerol, from about 10% w/w up to about 30 % w/w, as a plasticizer and pressed in a Carver press at 130° to 150°C. The resulting films exhibited a continuum of strength ranging from hard and brittle to tough and flexible. Treatment of some of these materials with water yields materials reminiscent of skin.
[00021] Numerous advantages of the disclosed compositions and processes have been set forth in the foregoing description, as exemplified by the disclosed preferred embodiments. It will be understood by those of skill in the art, however, that changes may be made in details, particularly in matters of reagents, concentrations, and step order, that do not require undue experimentation. All such changes in materials or processes are understood to be equivalent variants of the disclosure and to fall within the spirit and scope of the invention.

Claims

Claims
1. A composition comprising a wool containing fabric, wherein the wool has been treated by oxidation and ion exchange.
2. The composition of claim 1, wherein the oxidation treatment comprises soaking the fabric in an aqueous solution of from about 1-3% hydrogen peroxide at a temperature of from about 70° to about 100°C for a period of about 1-2 hours.
3. The composition of claim 1, wherein the ion exchange treatment comprises soaking the fabric in 0.1M NaOH or 0.1 M NB OH for about 16-20 hours.
4. The composition of claim 1, wherein a portion of the cystine residues in the wool have been lanthionized prior to oxidation.
5. The composition of claim 4, wherein the lanthionization treatment comprises soaking the fabric in a solution of a hydroxide base in a non-aqueous solvent at a temperature of 20°- 30°C for about 18-24 hours
6. The composition of claim 4, wherein the lanthionization treatment comprises soaking the fabric in a non-aqueous solution of 1.5% KOH, NaOH, NHjOH, LiOH, or Ca(OH)2.
7. The composition of claim 4, wherein the lanthionization treatment comprises soaking the fabric in a solution of a hydroxide base in an alcohol or aprotic solvent.
8. The composition of claim 7, wherein the solvent is ethanol, methanol, isopropanol, dimethylformamide, dimethyldisulfoxide, N-methylpyrrolidione, or hexamethylphosphoramide.
9. The composition of claim 4, wherein the lanthionization treatment comprises soaking the fabric in a 1.5% KOH/ETOH solution for a period of about 16-24 hours.
10. The composition of any of claims 1-9, wherein the fabric is a woven fabric comprising wool.
11. The composition of any of claims 1-9, wherein the fabric is a non- woven fabric comprising wool.
12. The composition of any of claims 1-9, wherein the fabric is wool felt, flannel, gabardine, worsted wool flannel, worsted wool flannel-cotton blend, worsted wool gabardine, or wool jersey knit.
13. The composition of any of claims 1-9, wherein the fabric is wool blended with cotton, polyester, rayon, silk, or nylon.
14. A wound dressing comprising the composition of any of claims 1-13.
15. The composition of any of claims 1-14, wherein the fabric is woven into a three - dimensional shape.
16. A keratin hydrogel comprising an oxidized, neutralized wool fabric.
17. The hydrogel of claim 16, wherein the fabric is a woven fabric comprising wool.
18. The hydrogel of claim 16„ wherein the fabric is a non-woven fabric containing wool.
19. The hydrogel of claim 16„ wherein the fabric is wool felt, flannel, gabardine, worsted wool flannel, worsted wool flannel-cotton blend, worsted wool gabardine, or wool jersey knit.
20. The hydrogel of claim 16, wherein the fabric is wool blended with cotton, polyester, rayon, silk, or nylon.
21. The hydrogel of any of claims 16-20, wherein the wool is partially lanthionized prior to oxidation.
22. The hydrogel of any of claims 16-21, wherein the wool is neutralized after oxidation in a solution of NaOH or NH4OH.
23. The hydrogel of any of claims 16-22, wherein the wool is oxidized by soaking the fabric in an aqueous solution of from about 1-3% hydrogen peroxide at a temperature of from about 70° to about 100°C for a period of about 1-2 hours.
24. The hydrogel of any of claims 21-23, wherein the wool is lanthionized in 1.5% KOH in ethanol.
25. A film comprising the composition of any of claims 1-24, and further comprising a plasticizer.
26. The film of claim 25, wherein the plasticizer is from 10-40% w/w glycerol.
27. The film of claim 25 or 26, wherein the film is produced by subjecting the fabric and plasticizer to a pressure of about 8,000-8,500 pounds at 130° to 150°C.
28. The wound dressing of claims 14, further comprising a backing material.
PCT/US2005/020404 2004-06-10 2005-06-09 Keratin based hydrogel sheets prepared from fabric for biomedical and other applications and method of production WO2005124011A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57857004P 2004-06-10 2004-06-10
US60/578,570 2004-06-10

Publications (1)

Publication Number Publication Date
WO2005124011A1 true WO2005124011A1 (en) 2005-12-29

Family

ID=35509704

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/020404 WO2005124011A1 (en) 2004-06-10 2005-06-09 Keratin based hydrogel sheets prepared from fabric for biomedical and other applications and method of production

Country Status (1)

Country Link
WO (1) WO2005124011A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9045600B2 (en) 2009-05-13 2015-06-02 Keraplast Technologies, Ltd. Biopolymer materials
EP2990413A4 (en) * 2013-04-25 2016-10-05 Spiber Inc Polypeptide porous body and method for producing same
WO2016156922A1 (en) * 2015-04-01 2016-10-06 Hodgson Alexandra Wool treatment process and products
US9732125B2 (en) 2013-04-25 2017-08-15 Spiber Inc. Polypeptide particle and method for producing same
US9968682B2 (en) 2013-04-25 2018-05-15 Spiber Inc. Polypeptide hydrogel and method for producing same
CN110684231A (en) * 2019-10-06 2020-01-14 武汉纺织大学 Flexible wool keratin fiber aerogel and preparation method thereof
WO2020068185A3 (en) * 2018-05-30 2020-05-28 Zymergen Inc. Monothioether crosslinkers in polymers and applications thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4378967A (en) * 1979-01-26 1983-04-05 Mitsubishi Gas Chemical Co., Inc. Process for bleaching fibrous material by hydrogen peroxide
US5304378A (en) * 1990-07-26 1994-04-19 Niigata Hi-Spinners Ltd. Wound dressing material
US6537326B1 (en) * 1997-09-26 2003-03-25 Wool Research Organisation Of New Zealand, Inc. Method for significantly enhancing the quality of scoured wool and machinery for achieving those enhancements

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4378967A (en) * 1979-01-26 1983-04-05 Mitsubishi Gas Chemical Co., Inc. Process for bleaching fibrous material by hydrogen peroxide
US5304378A (en) * 1990-07-26 1994-04-19 Niigata Hi-Spinners Ltd. Wound dressing material
US6537326B1 (en) * 1997-09-26 2003-03-25 Wool Research Organisation Of New Zealand, Inc. Method for significantly enhancing the quality of scoured wool and machinery for achieving those enhancements

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
1954, NEW YORK, article ALEXANDER ET AL.: "Wool its Chemistry and Physics.", pages: 254 - 255, XP008123592 *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9045600B2 (en) 2009-05-13 2015-06-02 Keraplast Technologies, Ltd. Biopolymer materials
US9968682B2 (en) 2013-04-25 2018-05-15 Spiber Inc. Polypeptide hydrogel and method for producing same
EP2990413A4 (en) * 2013-04-25 2016-10-05 Spiber Inc Polypeptide porous body and method for producing same
US10065997B2 (en) 2013-04-25 2018-09-04 Spiber Inc. Polypeptide porous body and method for producing same
US9732125B2 (en) 2013-04-25 2017-08-15 Spiber Inc. Polypeptide particle and method for producing same
CN106167985A (en) * 2015-04-01 2016-11-30 金羊毛新西兰有限公司 Pilus Caprae seu Ovis processing method and product
JP2018510979A (en) * 2015-04-01 2018-04-19 ウールケミー エヌゼット リミテッドWoolchemy Nz Limited Wool processing method and product
WO2016156922A1 (en) * 2015-04-01 2016-10-06 Hodgson Alexandra Wool treatment process and products
EP3277880A4 (en) * 2015-04-01 2018-09-12 Woolchemy NZ Limited Wool treatment process and products
AU2015389798B2 (en) * 2015-04-01 2021-07-22 Woolchemy Nz Limited Wool treatment process and products
US11236465B2 (en) 2015-04-01 2022-02-01 Woolchemy Nz Limited Wool treatment process and products
WO2020068185A3 (en) * 2018-05-30 2020-05-28 Zymergen Inc. Monothioether crosslinkers in polymers and applications thereof
CN110684231A (en) * 2019-10-06 2020-01-14 武汉纺织大学 Flexible wool keratin fiber aerogel and preparation method thereof
CN110684231B (en) * 2019-10-06 2022-02-25 武汉纺织大学 Flexible wool keratin fiber aerogel and preparation method thereof

Similar Documents

Publication Publication Date Title
JP3577083B2 (en) film
AU698087B2 (en) Improved soft tissue implant
WO2005124011A1 (en) Keratin based hydrogel sheets prepared from fabric for biomedical and other applications and method of production
Meena et al. Biomedical and industrial applications of collagen
US20090030454A1 (en) Resorbable implantable devices
AU2013273923C1 (en) Method for producing a collagen membrane and uses thereof
EP1888099B1 (en) Hydratable keratin compositions
EP1766125B1 (en) New and gentle process for conversion of cystine in keratin-containing materials to lanthionine
TW201429502A (en) Silk hydrogel composition and silk hydrogel mask
TWI287978B (en) Alginate composite fiber
JPH03242145A (en) Wound covering material and production thereof
JPH03242142A (en) Artificial skin and production thereof
Doillon Skin replacement using collagen extracted from bovine hide
AU2011203552B2 (en) New and gentle process for conversion of cystine in keratin-containing materials to lanthionine
JPH06125975A (en) Base material for curing wound
CN100342924C (en) Skin substitute and its preparation method
JPS62268875A (en) Fiber sheet like article
JPH03206032A (en) Wound-covering material
KR900006892B1 (en) Gelatin-based artificial skin of sponge type and the method of its method
CN116392646A (en) Barrier membrane for guiding bone regeneration
US20100056452A1 (en) Angiogenesis-promoting substrate
Shai et al. Skin substitutes and tissue-engineered skin equivalents
RO103994B1 (en) Method for waterproofing the textile vascular prothesis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase